Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

邮发代号 80-967

2019 Impact Factor: 3.421

Frontiers of Medicine  2014, Vol. 8 Issue (1): 106-112   https://doi.org/10.1007/s11684-014-0307-5
  RESEARCH ARTICLE 本期目录
Correlation of Twist upregulation and senescence bypass during the progression and metastasis of cervical cancer
Correlation of Twist upregulation and senescence bypass during the progression and metastasis of cervical cancer
Tian Wang, Yan Li, Abidan Tuerhanjiang, Wenwen Wang, Zhangying Wu, Ming Yuan, Shixuan Wang()
Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
 全文: PDF(300 KB)   HTML
Abstract

Cervical carcinoma is associated with high propensity for local invasion and lymph node metastasis. However, the molecular alterations that drive progression and metastasis of cervical cancer remain unclear. Cellular senescence has been proposed as the mechanism that protects an organism against cancer progression and metastasis. In addition, Twist, a basic helix-loop-helix transcription factor, has been suggested as an oncogene because it is overexpressed in many types of human cancer. This gene also exhibits a positive function in regulating invasion and metastasis. In this study, Twist was strongly and positively expressed in normal tissue, squamous cell carcinoma (SCC) IA--IIA, and SCC IIB--IIIB (4.3%, 44%, and 88.9%, respectively). The strong positive expressions of the senescence marker CBX3 were 39.1%, 32%, and 15.6%, respectively. The strong positive expressions of Twist in the SCC groups with or without lymph node metastasis were 80.8% and 50%. For CBX3, such expressions were 7.7% and 29.5%, respectively. Results also showed that the expression of Twist was inversely correlated with that of CBX3. Moreover, the knockdown of Twist with target siRNA in SiHa triggered the induction of the chromatin marker of the cellular senescence CBX3 and senescence-associated β-galactosidase activity. Our results suggested that the expression of Twist increased during the progression and metastasis of cervical cancer. Furthermore, Twist-induced senescence bypass is important in this process.

Key wordscervical cancer    senescence    Twist    CBX3    lymph node metastasis
收稿日期: 2013-08-08      出版日期: 2014-04-26
Corresponding Author(s): Wang Shixuan,Email:sxwang2012@hotmail.com   
 引用本文:   
. Correlation of Twist upregulation and senescence bypass during the progression and metastasis of cervical cancer[J]. Frontiers of Medicine, 2014, 8(1): 106-112.
Tian Wang, Yan Li, Abidan Tuerhanjiang, Wenwen Wang, Zhangying Wu, Ming Yuan, Shixuan Wang. Correlation of Twist upregulation and senescence bypass during the progression and metastasis of cervical cancer. Front Med, 2014, 8(1): 106-112.
 链接本文:  
https://academic.hep.com.cn/fmd/CN/10.1007/s11684-014-0307-5
https://academic.hep.com.cn/fmd/CN/Y2014/V8/I1/106
Fig.1  
Twist expression (%)Total
-++ ++ + +
Normal16 (69.6)6 (26.1)1 (4.3)0 (0)23
SCC IA-IIA0 (0)14 (56.0)10 (40.0)1 (4.0)25
SCC IIB-IIIB0 (0)5 (11.1)33 (73.3)7 (15.6)45
Tab.1  
Twist expression (%)Total
-++ ++ + +
LN -0 (0%)16 (36.4%)27 (61.3%)1 (2.3%)44
LN+0 (0%)3 (11.5%)16 (61.6%)7 (26.9%)26
Tab.2  
CBX3 expression (%)Total
-++ ++ + +
Normal4 (17.4)10 (43.5)5 (21.7)4 (17.4)23
SCC IA-IIA9 (36)8 (32)6 (24)2 (8)25
SCC IIB-IIIB19 (42.2)19 (42.2)6 (13.4)1 (2.2)45
Tab.3  
CBX3 expression (%)Total
-++ ++ + +
LN-16 (36.4%)15 (34.1%)10 (22.7%)3 (6.8%)44
LN+12 (46.2%)12 (46.1%)2 (7.7%)0 (0%)26
Tab.4  
Fig.2  
1 zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2(5): 342-350
doi: 10.1038/nrc798 pmid:12044010
2 Ozalp S, Yalcin OT, Oner U, Tanir HM, Acikalin M, Sarac I. Microvessel density as a prognostic factor in preinvasive and invasive cervical lesions. Eur J Gynaecol Oncol 2003; 24(5): 425-428
pmid:14584662
3 Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192(4): 547-556
doi: 10.1083/jcb.201009094 pmid:21321098
4 Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, ?rntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444(7119): 633-637
doi: 10.1038/nature05268 pmid:17136093
5 Huang Y, Myers MP, Xu RM. Crystal structure of the HP1-EMSY complex reveals an unusual mode of HP1 binding. Structure 2006; 14(4): 703-712
doi: 10.1016/j.str.2006.01.007 pmid:16615912
6 Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 2012; 22(3): 194-207
doi: 10.1016/j.semcancer.2012.02.013 pmid:22406545
7 Prieur A, Peeper DS. Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 2008; 20(2): 150-155
doi: 10.1016/j.ceb.2008.01.007 pmid:18353625
8 Smit MA, Peeper DS. Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY) 2010; 2(10): 735-741
pmid:20975209
9 Qin Q, Xu Y, He T, Qin C, Xu J. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res 2012; 22(1): 90-106
doi: 10.1038/cr.2011.144 pmid:21876555
10 Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R, Voeltzel T, Selmi A, Valsesia-Wittmann S, Caron de Fromentel C, Puisieux A. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008; 14(1): 79-89
doi: 10.1016/j.ccr.2008.06.005 pmid:18598946
11 Kwok WK, Ling MT, Yuen HF, Wong YC, Wang X. Role of p14ARF in TWIST-mediated senescence in prostate epithelial cells. Carcinogenesis 2007; 28(12): 2467-2475
doi: 10.1093/carcin/bgm185 pmid:17690110
12 Li Y, Wang W, Wang W, Yang R, Wang T, Su T, Weng D, Tao T, Li W, Ma D, Wang S. Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. Gynecol Oncol 2012; 124(1): 112-118
doi: 10.1016/j.ygyno.2011.09.003 pmid:22018873
13 Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94(2): 153-156
doi: 10.1002/ijc.1440 pmid:11668491
14 Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90
doi: 10.3322/caac.20107 pmid:21296855
16 Chandeck C, Mooi WJ. Oncogene-induced cellular senescence. Adv Anat Pathol 2010; 17(1): 42-48
pmid:20032638
17 Foroni C, Broggini M, Generali D, Damia G. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 2012; 38(6): 689-697
doi: 10.1016/j.ctrv.2011.11.001 pmid:22118888
18 Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007; 67(5): 1979-1987
doi: 10.1158/0008-5472.CAN-06-1479 pmid:17332325
19 Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL, Fan ST. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006; 12(18): 5369-5376
doi: 10.1158/1078-0432.CCR-05-2722 pmid:17000670
20 Lee KW, Kim JH, Han S, Sung CO, Do IG, Ko YH, Um SH, Kim SH. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Ann Surg Oncol 2012; 19(1): 326-335
doi: 10.1245/s10434-011-1867-0 pmid:21732143
21 Kajiyama H, Shibata K, Umezu T, Mizuno M, Suzuki S, Yamamoto E, Fujiwara S, Kikkawa F. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement. Hum Pathol 2013; 44(2): 181-188
doi: 10.1016/j.humpath.2012.05.015 pmid:22974479
22 Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139(5): 871-890
doi: 10.1016/j.cell.2009.11.007 pmid:19945376
23 Pedraza-Fari?a LG. Mechanisms of oncogenic cooperation in cancer initiation and metastasis. Yale J Biol Med 2006; 79(3-4): 95-103
pmid:17940619
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed